{
  "ptid_time": "123_S_2055_2012-09-24",
  "img_path": "/data/qiuhui/data/adni/images/123_S_2055/2012-09-24/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 7,166 mm³, 5.2% below the reference mean. With a Z-score of -0.51 (30.6th percentile), this represents normal volume ; whole brain volume measures 1,073,300 mm³, 0.6% below the reference mean. With a Z-score of -0.07 (47.1th percentile), this represents normal volume ; entorhinal cortex volume measures 3,778 mm³, 7.9% below the reference mean. With a Z-score of -0.53 (29.7th percentile), this represents normal volume ; fusiform gyrus volume measures 15,794 mm³, 16.2% below the reference mean. With a Z-score of -1.38 (8.4th percentile), this represents mild atrophy; middle temporal gyrus volume measures 19,397 mm³, 9.1% below the reference mean. With a Z-score of -0.82 (20.7th percentile), this represents normal volume . ",
  "text_data": "Age is 77.2 years. Gender is Male. Education: 18 years. MMSE: 25.0. MoCA: 21.0. Logical Memory: 9.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.34 SUVR (significant elevated); Amyloid beta: 548.20 pg/mL (mild reduced); Total tau: 424.10 pg/mL (significant elevated); Phosphorylated tau: 42.15 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The hippocampal, whole brain, and entorhinal cortex volumes are within normal ranges, while the fusiform gyrus shows mild atrophy. Cognitive testing (MMSE 25, MoCA 21) indicates mild cognitive impairment, supported by biomarker evidence of amyloid pathology (Aβ reduction, elevated tau, and AV45).  \nDiagnosis: MCI  \nConfidence: Medium  \n\n(Confidence is medium due to the presence of biomarker abnormalities and cognitive decline, but the structural atrophy is not severe enough to definitively diagnose dementia.)",
  "timestamp": "2025-07-26T12:30:05.898793"
}